Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
22 December 2024
| Name: | INNLANZ LIMITED (INL) | ||||||
| ISIN: | AU0000035362 | ||||||
| Date of Listing: | 22 February 2019 | ||||||
| Date of Delisting: | 05 August 2024 | ||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 05 August 2024.Legal Status:
ACN: 628 420 824ABN: 83 628 420 824
Registration Date: 27 August 2018
Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| INNLANZ LIMITED | 16/12/2021 | |
| MEDILAND PHARM LIMITED | 16/12/2021 |
REGISTRY:
Computershare Sydney
6 Hope St Ermington NSW 2115
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 13/09/2024 |
delisted at entity's request under Listing Rule 17.11 | 05/08/2024 |
we understand the company delisted because of the costs of the listing, low level of trading on ASX and the impact of small trades on the share price - prior to delisting the company offered $0.013 to buy shares in an off-market buy-back | 05/08/2024 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 31/07/2024 |
The company releases a notification of cessation of securities. | 31/07/2024 |
The securities of Innlanz Limited will be suspended from quotation at the close of trading today, Tuesday, 30 July 2024 under Listing Rule 17.2, at the request of INL, pending removal of INL from the official list of ASX Limited | 30/07/2024 |
The suspension of trading in the securities of Innlanz Limited will be lifted from the commencement of trading today, Monday, 11 March 2024 following lodgement of its half year accounts for the period ended 31 December 2023. | 11/03/2024 |
The company lodges its Half Year Accounts. | 07/03/2024 |
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Friday, 1 March 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 29 February 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/03/2024 |
name changed from Mediland Pharm Limited | 16/12/2021 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 13/09/2024 |
delisted at entity's request under Listing Rule 17.11 | 05/08/2024 |
we understand the company delisted because of the costs of the listing, low level of trading on ASX and the impact of small trades on the share price - prior to delisting the company offered $0.013 to buy shares in an off-market buy-back | 05/08/2024 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 31/07/2024 |
The company releases a notification of cessation of securities. | 31/07/2024 |
The securities of Innlanz Limited will be suspended from quotation at the close of trading today, Tuesday, 30 July 2024 under Listing Rule 17.2, at the request of INL, pending removal of INL from the official list of ASX Limited | 30/07/2024 |
The suspension of trading in the securities of Innlanz Limited will be lifted from the commencement of trading today, Monday, 11 March 2024 following lodgement of its half year accounts for the period ended 31 December 2023. | 11/03/2024 |
The company lodges its Half Year Accounts. | 07/03/2024 |
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Friday, 1 March 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 29 February 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/03/2024 |
name changed from Mediland Pharm Limited | 16/12/2021 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 31/12/2019 | Leo Cui | 31,000 | $0.275 | $8,509 | |
| 16/12/2019 | Leo Cui | 30,000 | $0.275 | $8,250 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Peter French | Non Exec Chairman | 22/02/2019 |
| Yesh Mudaliar | Managing Director | 22/02/2019 |
| Jessie Tao | CFO | 22/02/2019 |
| Theo Renard | Non Exec Director | 26/01/2019 |
| Leo Cui | Director | 29/11/2019 |
| Indira Naidu | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Jhon Shen | Executive Director | 22/02/2019 | 27/02/2024 |
| Tracey Cray | Non Exec Director | 22/02/2019 | 31/07/2022 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
